Addressing BBV and STI-related stigma in healthcare: New resources for healthcare services now available

The DruGS team has recently published an implementation guide to support healthcare workers to use the blood-borne viruses (BBV) and sexually transmissible infections (STI) stigma reduction toolkit. In 2022 the team published the practice-ready stigma reduction toolkit designed to be used by individual healthcare professionals and services to tackle stigma and discrimination related to BBVs…

Understanding women’s perspectives on take-home naloxone: New research broadsheet and overdose response resources

The DruGS team has just completed an innovative project exploring women’s perspectives on take-home naloxone, a drug that can temporarily reverse opioid overdose. While research suggests that gender can shape engagement with harm reduction initiatives such as take-home naloxone programs, these issues have only been fleetingly been acknowledged in available research. Responding to this, the…

DruGS research showcased at 2023 CDP conference, Paris

In September, DruGS team members travelled to Paris, France, to take part in the Contemporary Drug Problems conference. Co-convened by the journal’s co-editors Associate Professor Kate Seear and Professor kylie valentine along with the conference organising committee, this year’s conference theme was ‘Embracing trouble: New ways of doing, being and knowing’. The theme aimed to…

DruGS team to present research in Sweden and Portugal

November sees members of the DruGS Program travel to Europe to present a range of conference and seminar papers. DruGS Program Lead Professor Suzanne Fraser will present at a seminar hosted by Professor Mats Ekendahl (a DruGS Program collaborator) at the Department of Social Work, Stockholm University (8 November), and at the European Conference on…

Launching Vital Voices website

In May, members of the DruGS team will attend the 13th annual Australasian Viral Hepatitis Conference (29 to 31 May). This conference is a key event for researchers, practitioners and policy makers working in viral hepatitis and related areas, and is an important opportunity to showcase key outcomes for our Australian Research Council-funded project, ‘Lived…

Telehealth for hepatitis C treatment during the pandemic: What works?

In 2021 the DruGS team conducted an Australian Government Department of Health-funded qualitative study on telehealth treatment for hepatitis C during the COVID-19 pandemic. The final report from the project has just been launched via webinar, and featured presentations on the findings and recommendations and a panel discussion spanning harm reduction and peer support, advocacy…

Telehealth for hepatitis C treatment during COVID-19

On World Hepatitis Day, the DruGS team reflects on preliminary findings from a research project exploring how telehealth has shaped hepatitis treatment during the COVID crisis. Funded by the Commonwealth Department of Health, this qualitative interview-based project aims to understand the benefits, limitations and effects of the use of telehealth for hepatitis C treatment during…

Presentation at the South Western Sydney Partnership event

Since 2019 members of the DruGS team have been very busy conducting a series of qualitative projects with South Western Sydney Local Health District Drug Health Services. These projects cover a range of important issues including: stigma in alcohol and other drug service delivery, improving youth outreach and heavy drinking and alcohol-related health issues. Recently,…

NGV: Kate Seear presents on Haring, Basquiat and the politics of death

On Friday March 13, DruGS program team members Associate Professor Kate Seear and Professor Suzanne Fraser took part in La Trobe University’s Bold Thinking Public Lecture Series at the the National Gallery of Victoria. The public lecture, delivered by Kate, responded to the NGV’s current exhibition Haring Basquiat, finding much to discuss of relevance to…